Literature DB >> 6981061

Monoclonal murine anti-nucleic acid antibody with double-stranded specificity.

D W Ballard, E W Voss.   

Abstract

The NZB/NZW F1 murine model for the autoimmune disease systemic lupus erythematosus (SLE) has been employed in somatic cell hybridizations to develop hybridoma autoantibodies with double-stranded (ds) DNA specificity. Monoclonal anti-DNA antibodies from one hybridoma cell line were purified and analysed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and isoelectric focusing. Results of comparative binding studies with tritiated [3H]-colicin E1 plasmid DNA probes suggested preferential binding for the native DNA conformation relative to single-stranded DNA. [3H]dsDNA binding was inhibited by several ribohomopolymers (poly G, U and I) but not by free nucleotides, indicating that the phosphodiester-ribose backbone may contribute to the binding specificity of the clonotype.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6981061     DOI: 10.1016/0161-5890(82)90005-0

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  5 in total

Review 1.  Origins of anti-DNA autoantibodies.

Authors:  R S Schwartz; B D Stollar
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

2.  In vivo clearance and tissue uptake of an anti-DNA monoclonal antibody and its complexes with DNA.

Authors:  E Ben Chetrit; E H Dunsky; S Wollner; D Eilat
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

3.  Anti-DNA antibodies: problems in their study and interpretation.

Authors:  D Eilat
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

4.  Variations in duplex DNA conformation detected by the binding of monoclonal autoimmune antibodies.

Authors:  R P Braun; J S Lee
Journal:  Nucleic Acids Res       Date:  1986-06-25       Impact factor: 16.971

5.  Description and partial characterization of a nucleolar RNA-associated autoantigen defined by a human monoclonal antibody.

Authors:  N Chiorazzi; W H Reeves
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.